subject: UMLS:C5552625

subject_name: Interferon alfa-2b [EPC]


subject: UMLS:C5552625

object_name: hepatitis

tested_intervention: unsure


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Urinary Urgency

tested_intervention: yes


subject: CHEBI:5520

subject_name: gonadorelin

object_name: Ovulation disorder


subject: UMLS:C0306166

subject_name: Factrel


subject: UMLS:C1572759

subject_name: MONOHYDRATE

object_name: chronic hepatitis B virus infection


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: uveitis


subject: CHEBI:201431

object_name: Uveitis, CTCAE


subject: CHEBI:201431

object_name: juvenile idiopathic arthritis


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:28787

subject_name: Nitroglycerin

object_name: glaucoma


subject: CHEBI:28787

object_name: Glaucoma, CTCAE


subject: PUBCHEM.COMPOUND:129009970

subject_name: Sodium-nitroprusside


subject: PUBCHEM.COMPOUND:129009970


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Acute lung injury/Acute respiratory distress syndrome (ARDS)


subject: CHEBI:9168

object_name: respiratory failure


subject: CHEBI:9168

object_name: Respiratory Failure, CTCAE


subject: PUBCHEM.COMPOUND:56674991

subject_name: Brincidofovir

object_name: BK virus infection


subject: PUBCHEM.COMPOUND:56674991

object_name: kidney disorder


subject: CHEBI:9984

subject_name: vincaleukoblastine sulfate

object_name: bladder tumor


subject: CHEBI:9984

object_name: urinary bladder carcinoma


subject: CHEBI:9984

object_name: urinary bladder cancer


subject: CHEBI:9984

object_name: childhood bladder carcinoma


subject: PR:000007022

subject_name: ETS-related transcription factor Elf-3

object_name: Gaucher disease


subject: UMLS:C3853844

object_name: prostate carcinoma


subject: UMLS:C3853844

object_name: prostate cancer


subject: UMLS:C0086555

subject_name: licorice

object_name: apparent mineralocorticoid excess


subject: UMLS:C5575555

subject_name: Liquorice antigen


subject: CHEBI:28177

subject_name: Theophylline


subject: UMLS:C2728191

subject_name: Licorice


subject: CHEBI:74705

subject_name: Met-Leu

object_name: heart failure


subject: CHEBI:74705

object_name: Heart Failure, CTCAE


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UMLS:C3467937

subject_name: PSI 6130 Diisobutyrate

object_name: hepatitis C


subject: CHEBI:16796

subject_name: Melatonin

object_name: Chronic low back pain


subject: UNII:000705ZASD

subject_name: adecatumumab

object_name: Metastatic malignant neoplasm to liver


subject: UNII:000705ZASD

object_name: colorectal cancer


subject: UNII:000705ZASD

object_name: colorectal carcinoma


subject: UNII:000705ZASD

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1741817


subject: UMLS:C1741817


subject: UMLS:C1741817


subject: UMLS:C1741817


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix

object_name: castration-resistant prostate carcinoma


subject: UMLS:C0971731


subject: CHEBI:134689

subject_name: Rucaparib

object_name: Adenocarcinoma of the prostate metastatic


subject: CHEBI:134689

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:134689

object_name: Stage IVB Prostate Cancer AJCC v8


subject: CHEBI:134689

object_name: Stage IVA Prostate Cancer AJCC v8


subject: CHEBI:62880

subject_name: Veliparib

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:62880

object_name: Refractory acute myeloid leukemia


subject: CHEBI:62880


subject: CHEBI:62880

object_name: myelofibrosis


subject: UMLS:C5783498

subject_name: Aminolevulinic Acid Intravenous Formulation SONALA-001

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C5783498

object_name: Recurrent Glioblastoma


subject: CHEBI:80343

subject_name: Mecasermin

object_name: Tendinopathy


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Genitourinary Cancer


subject: PR:000001379


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: UMLS:C5237235

subject_name: Neoantigen-based Therapeutic Cancer Vaccine GRT-C903

object_name: Childhood Breast Carcinoma


subject: UMLS:C5237235

object_name: breast carcinoma


subject: UMLS:C5237235

object_name: breast cancer


subject: UMLS:C5237235

object_name: ovarian cancer


subject: UMLS:C5237235

object_name: ovarian neoplasm


subject: UMLS:C5237235

object_name: ovarian carcinoma


subject: UMLS:C5237235


subject: UMLS:C5237235

object_name: digestive system cancer


subject: UMLS:C5237236

subject_name: Neoantigen-based Therapeutic Cancer Vaccine GRT-R904


subject: UMLS:C5237236


subject: UMLS:C5237236


subject: UMLS:C5237236


subject: UMLS:C5237236


subject: UMLS:C5237236


subject: UMLS:C5237236


subject: UMLS:C5237236


subject: CHEBI:135686

subject_name: Alvimopan

object_name: Postoperative ileus


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Antiphospholipid syndrome in pregnancy


subject: CHEBI:5801

object_name: Adverse effects in the therapeutic use of anticoagulants


subject: CHEBI:5801

object_name: Poisoning by, adverse effect of and underdosing of anticoagulants


subject: CHEBI:5801

object_name: Poisoning by anticoagulant


subject: MESH:C073590

subject_name: gadolinium ethoxybenzyl DTPA

object_name: liver carcinoma


subject: MESH:C073590

object_name: liver cancer


subject: MESH:C073590

object_name: liver neoplasm


subject: MESH:C073590

object_name: Adult Liver Carcinoma


subject: UMLS:C3853628

subject_name: Granule

object_name: rheumatoid arthritis


subject: UMLS:C5670500

subject_name: Gefurulimab

object_name: proteinuria


subject: UMLS:C5670500

object_name: Proteinuria of undiagnosed cause


subject: UMLS:C5670500

object_name: Proteinuria, CTCAE 3.0


subject: UMLS:C5670500

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:499361

subject_name: Aprepitant

object_name: gastroparesis


subject: CHEBI:499361

object_name: Gastroparesis, CTCAE


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: Follicular lymphoma refractory


subject: UNII:LDJ89SS0YG

object_name: Follicular lymphoma recurrent


subject: UMLS:C4329313


subject: UMLS:C4329313


subject: CHEBI:229212

subject_name: Pirtobrutinib


subject: CHEBI:229212

object_name: grade 3A follicular lymphoma


subject: CHEBI:229212

object_name: Lymphoma, Mixed-Cell, Follicular


subject: CHEBI:229212

object_name: Lymphoma, Small Cleaved-Cell, Follicular


subject: CHEBI:229212


subject: UNII:939U7C91AI

subject_name: Solriamfetol

object_name: multiple sclerosis


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Brain Stem Glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C3526551

subject_name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Absorbed and Inactivated Poliovirus (DTaP-IPV) Vaccine

object_name: hepatitis B


subject: MESH:C055753

subject_name: Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate


subject: MESH:D000082082

subject_name: Immune Checkpoint Inhibitors

object_name: EXCESS LMW-DNA


subject: MESH:D000082082

object_name: Sicca Syndrome


subject: PUBCHEM.COMPOUND:21014972

subject_name: Telavancin

object_name: Pregnant


subject: CHEBI:176724

subject_name: Etiracetam

object_name: Canavan disease


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: CHEBI:8382

subject_name: Prednisone


subject: DRUGBANK:DB17075


subject: UMLS:C5709321


subject: UMLS:C0444626

subject_name: Crystal Structure

object_name: Oral health


subject: UMLS:C4551577

subject_name: Crystal - natural material


subject: UMLS:C4053648

subject_name: EC-18 cpd

object_name: atopic eczema


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Fetal Death


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:9566855ULN

subject_name: ISOBUTAMBEN

object_name: Uses contraception (finding)


subject: UNII:9566855ULN


subject: CHEBI:6759

subject_name: Mepivacaine


subject: CHEBI:6759


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: osteoporosis


subject: CHEBI:8228

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:8228

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:8228

object_name: Osteoporosis, CTCAE 3.0


subject: UNII:7DR7JMB8BH

object_name: Metastatic non-small cell lung cancer


subject: UNII:7DR7JMB8BH

object_name: Childhood Solid Neoplasm


subject: UNII:7DR7JMB8BH

object_name: Adult Solid Neoplasm


subject: UNII:SMA5ZS5B22

subject_name: Ensartinib


subject: UNII:SMA5ZS5B22


subject: UNII:SMA5ZS5B22


subject: CHEBI:50992

object_name: type 1 diabetes mellitus


subject: UMLS:C3537039

subject_name: Thiazolidinedione [EPC]


subject: CHEBI:50990

subject_name: thiazolidinediones


subject: CHEBI:8884

subject_name: Rocuronium

object_name: Caesarean section


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: CHEBI:45652

subject_name: Succinylcholine


subject: CHEBI:45652


subject: CHEBI:7514

subject_name: Neostigmine


subject: UNII:AX2VWG0ZCR

subject_name: ZUNSEMETINIB

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UNII:AX2VWG0ZCR

object_name: pancreatic neoplasm


subject: UNII:AX2VWG0ZCR

object_name: exocrine pancreatic carcinoma


subject: UNII:AX2VWG0ZCR

object_name: malignant pancreatic neoplasm


subject: DRUGBANK:DB16502

subject_name: Zunsemetinib


subject: DRUGBANK:DB16502


subject: DRUGBANK:DB16502


subject: DRUGBANK:DB16502


subject: CHEBI:74705

object_name: recurrent hypersomnia


subject: CHEBI:74705

object_name: idiopathic hypersomnia


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318


subject: PR:000016318


subject: UMLS:C1721789

subject_name: Cervarix

object_name: HPV-associated cervical carcinoma


subject: UMLS:C1721789

object_name: cervical intraepithelial neoplasia


subject: UMLS:C1721789

object_name: dysplasia of cervix


subject: RXCUI:659877

subject_name: Gardasil


subject: UMLS:C0360686

subject_name: Zinc-containing product in oral dose form

object_name: pervasive developmental disorder


subject: UMLS:C0360686

object_name: autism


subject: UMLS:C0360686

object_name: autism spectrum disorder


subject: CHEBI:76842

object_name: Spinal fusion acquired


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:8988

object_name: Recurrent Childhood Gliosarcoma


subject: CHEBI:8988

object_name: Recurrent Gliosarcoma


subject: CHEBI:8988

object_name: Recurrent WHO Grade 3 Glioma


subject: CHEBI:8988

object_name: Recurrent Childhood Anaplastic Oligodendroglioma


subject: CHEBI:8988

object_name: Recurrent Anaplastic Oligodendroglioma


subject: CHEBI:8988

object_name: Recurrent Anaplastic Astrocytoma


subject: CHEBI:8988

object_name: Recurrent Childhood Anaplastic Astrocytoma


subject: CHEBI:8988

object_name: Recurrent Childhood Anaplastic Oligoastrocytoma


subject: CHEBI:8988

object_name: Recurrent Anaplastic Oligoastrocytoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:90881

subject_name: Camptosar


subject: CHEBI:90881


subject: CHEBI:90881

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:90881

object_name: Recurrent Glioblastoma


subject: CHEBI:90881


subject: CHEBI:90881

object_name: Recurrent Malignant Glioma


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: CHEBI:90881


subject: UMLS:C1268855

subject_name: Gonadotropin releasing hormone antagonist

object_name: Endocrine female infertility


subject: UMLS:C1268855

object_name: Female infertility due to ovulatory disorder


subject: UMLS:C1268855

object_name: Female infertility of other origin


subject: UMLS:C1268855

object_name: Female infertility of tubal origin


subject: UMLS:C1268855

object_name: Female infertility due to tubal block


subject: UMLS:C1268855

object_name: Female infertility - cervical/vaginal


subject: UMLS:C1268855

object_name: Female infertility due to tubal occlusion


subject: UMLS:C1268855

object_name: primary ovarian failure


subject: UMLS:C1268855

object_name: premature menopause


subject: UMLS:C1268855

object_name: Infection of uterus


subject: UMLS:C1268855

object_name: uterine anomalies


subject: UMLS:C1268855

object_name: ectopic pregnancy


subject: UMLS:C1268855

object_name: hydrosalpinx


subject: UMLS:C1268855

object_name: salpingitis


subject: UMLS:C1268855

object_name: uterine fibroid


subject: UMLS:C1268855

object_name: leiomyoma


subject: UMLS:C3537040

subject_name: Gonadotropin Releasing Hormone Antagonist [EPC]


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C3537040


subject: UMLS:C1522385

subject_name: Recombinant Gonadotropin


subject: UMLS:C1522385


subject: UMLS:C1522385


subject: UMLS:C1522385


subject: UMLS:C1522385


subject: UMLS:C1522385


subject: UMLS:C1522385


subject: UMLS:C1522385


subject: UMLS:C1522385


subject: UMLS:C1522385


subject: UMLS:C1522385


subject: UMLS:C1522385


subject: UMLS:C1522385

object_name: endometriosis


subject: UMLS:C1522385


subject: UMLS:C1522385


subject: UMLS:C1522385


subject: UMLS:C0018061

subject_name: Gonadotropins

object_name: Endocrine female infertility


subject: UMLS:C0018061

object_name: Female infertility due to ovulatory disorder


subject: UMLS:C0018061

object_name: Female infertility of other origin


subject: UMLS:C0018061

object_name: Female infertility of tubal origin


subject: UMLS:C0018061

object_name: Female infertility due to tubal block


subject: UMLS:C0018061

object_name: Female infertility - cervical/vaginal


subject: UMLS:C0018061

object_name: Female infertility due to tubal occlusion


subject: UMLS:C0018061

object_name: primary ovarian failure


subject: UMLS:C0018061

object_name: premature menopause


subject: UMLS:C0018061

object_name: Infection of uterus


subject: UMLS:C0018061

object_name: uterine anomalies


subject: UMLS:C0018061

object_name: ectopic pregnancy


subject: UMLS:C0018061


subject: UMLS:C0018061

object_name: hydrosalpinx


subject: UMLS:C0018061

object_name: salpingitis


subject: UMLS:C0018061


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)


subject: CHEBI:81570


subject: CHEBI:81570


subject: CHEBI:81570


subject: CHEBI:81570


subject: CHEBI:81570


subject: CHEBI:81570


subject: CHEBI:81570


subject: CHEBI:81570


subject: CHEBI:81570


subject: CHEBI:81570


subject: CHEBI:81570


subject: CHEBI:81570


subject: CHEBI:81570


subject: CHEBI:81570


subject: CHEBI:81570


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C0309130


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: UMLS:C1141639


subject: GTOPDB:1160

subject_name: hCG


subject: GTOPDB:1160


subject: GTOPDB:1160


subject: GTOPDB:1160


subject: GTOPDB:1160


subject: GTOPDB:1160


subject: GTOPDB:1160


subject: GTOPDB:1160


subject: GTOPDB:1160


subject: GTOPDB:1160


subject: GTOPDB:1160


subject: GTOPDB:1160


subject: GTOPDB:1160


subject: GTOPDB:1160


subject: GTOPDB:1160


subject: GTOPDB:1160

object_name: uterine fibroid


subject: GTOPDB:1160

object_name: leiomyoma


subject: UNII:3Y31FJ8K50

subject_name: TARLOXOTINIB BROMIDE

object_name: EGFR Exon 20 Insertion Mutation


subject: UNII:3Y31FJ8K50

object_name: NRG1 Gene Fusion Positive


subject: UNII:3Y31FJ8K50

object_name: Metastatic non-small cell lung cancer


subject: UNII:3Y31FJ8K50

object_name: Non-small cell lung cancer recurrent


subject: UNII:3Y31FJ8K50

object_name: Non-small cell lung cancer stage IIIB


subject: UMLS:C4726810

subject_name: Tarloxotinib Bromide


subject: UMLS:C4726810


subject: UMLS:C4726810


subject: UMLS:C4726810


subject: UMLS:C4726810


subject: UMLS:C5203530

subject_name: Tranexamic Acid Liquid Injection

object_name: Drug usage


subject: UMLS:C5203530

object_name: Drug use history


subject: UMLS:C5203530

object_name: Encounter due to drug use


subject: CHEBI:94518

subject_name: Tranexamic acid


subject: CHEBI:94518


subject: CHEBI:94518


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Locally Advanced Breast Carcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:64816


subject: CHEBI:64816

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:61397

subject_name: Neratinib


subject: CHEBI:61397

object_name: inflammatory breast carcinoma


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: CHEBI:231601

subject_name: trastuzumab


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C3852577

subject_name: Oralair

object_name: Allergy


subject: UMLS:C3852577

object_name: History of allergies


subject: CHEBI:6775

subject_name: Mesalazine

object_name: collagenous colitis


subject: CHEBI:36791

subject_name: Escitalopram

object_name: CHEST PAIN RULE OUT MYOCARDIAL INFARCTION


subject: CHEBI:3723

subject_name: Citalopram


subject: UMLS:C1565135

subject_name: Ethyl-EPA

object_name: cardiovascular disorder


subject: UMLS:C1565135

object_name: arteriosclerosis disorder


subject: UMLS:C1565135

object_name: atherosclerosis


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: autoimmune thrombocytopenia


subject: CHEBI:27300

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:27300

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: bariatric surgery candidate


subject: CHEBI:31186

subject_name: Alfacalcidol

object_name: Paresis


subject: CHEBI:31186

object_name: Muscle weakness


subject: CHEMBL.COMPOUND:CHEMBL1201599

subject_name: HUMAN IMMUNOGLOBULIN G

object_name: adult dermatomyositis


subject: CHEMBL.COMPOUND:CHEMBL1201599

object_name: dermatomyositis


subject: UMLS:C3467713

subject_name: Human Immunoglobulin G [EPC]


subject: UMLS:C3467713


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: High grade glioma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: IgA vasculitis


subject: UMLS:C0017007

subject_name: Gamma globulin


subject: UMLS:C1330099

subject_name: Biothrax

object_name: anthrax disease


subject: UMLS:C0963149

subject_name: Definity

object_name: cor pulmonale


subject: CHEBI:31980

subject_name: Perflutren


subject: CHEBI:134990

subject_name: Agomelatine

object_name: Acute Ischemic Stroke


subject: CHEBI:134990

object_name: Ischemic stroke


subject: UNII:TT3345YXVR

subject_name: Verdiperstat

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:TT3345YXVR

object_name: amyotrophic lateral sclerosis


subject: CHEBI:33942

subject_name: ribose

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: CHEBI:27476

subject_name: beta-D-Ribopyranose

object_name: fibromyalgia


subject: CHEBI:27476


subject: CHEBI:45506

subject_name: alpha-D-ribose


subject: CHEBI:45506


subject: CHEBI:47013

subject_name: D-ribofuranose


subject: CHEBI:31348

subject_name: Capecitabine

object_name: anal canal cancer


subject: CHEBI:25357

subject_name: mitomycin


subject: UNII:V03E10691T

subject_name: MITOMYCINS


subject: UNII:V03E10691T

object_name: anal canal carcinoma


subject: UMLS:C3641657

subject_name: CEND 1

object_name: Metastatic malignant neoplasm to liver


subject: UMLS:C3641657

object_name: Secondary malignant neoplasm of lung


subject: UMLS:C3641657

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C3641657

object_name: stage IV pancreatic cancer


subject: UMLS:C3641657

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UMLS:C3641657

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C3641657

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C3641657

object_name: Carcinoma breast stage IV


subject: UMLS:C3641657

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C3641657

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C3641657

object_name: Breast cancer recurrent


subject: UMLS:C3641657

object_name: pancreatic acinar cell carcinoma


subject: UNII:LNU830UGAX

subject_name: AFIMKIBART

object_name: Crohn disease


subject: PR:000017019

subject_name: UBX domain-containing protein 11

object_name: interstitial lung disease 1


subject: PR:000017019

object_name: interstitial lung disease 2


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1518041

object_name: obesity


subject: UMLS:C1518041

object_name: Obesity, CTCAE


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: digestive system neoplasm


subject: UNII:CJN36EQM0H

object_name: Neoplasm of the gastrointestinal tract


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: HER2 positive breast carcinoma


subject: CHEBI:74327

subject_name: Ile-Val


subject: UNII:UX33I93GLS

subject_name: Barusiban

object_name: infertility


subject: UMLS:C1872192

subject_name: barusiban


subject: GTOPDB:13316

subject_name: maridebart cafraglutide

object_name: atherosclerosis


subject: UNII:Z24U3U73HN

subject_name: MARIDEBART CAFRAGLUTIDE


subject: UMLS:C5855458

subject_name: Maridebart Cafraglutide


subject: CHEBI:8427

subject_name: Probucol

object_name: hyperlipoproteinemia


subject: CHEBI:8427

object_name: Hyperlipidemia, CTCAE


subject: CHEBI:8427

object_name: Serum lipids high (finding)


subject: UNII:X00B0D5O0E

subject_name: PIPERACILLIN

object_name: tracheobronchitis


subject: CHEBI:8232

subject_name: Piperacillin


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Insulin resistance


subject: CHEBI:18258

subject_name: Liothyronine

object_name: Carcinoma breast stage IV


subject: CHEBI:18258

object_name: Thyroid dysfunction


subject: UMLS:C2936843

subject_name: l-Triiodothyronine [EPC]


subject: UMLS:C2936843


subject: CHEBI:39548

object_name: Heart failure with reduced ejection fraction


subject: CHEBI:63626

subject_name: Tesamorelin

object_name: HIV lipodystrophy


subject: UMLS:C1313807


subject: CHEBI:167309

subject_name: Methadone

object_name: Bone fracture


subject: CHEBI:167309

object_name: Fracture, CTCAE


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Breast Pain, CTCAE 5.0


subject: CHEBI:41879

object_name: Mastalgia


subject: CHEBI:41879

object_name: BREAST PAIN FEMALE


subject: CHEBI:41879

object_name: Breast Pain, CTCAE 3.0


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Adult Meningioma


subject: CHEBI:50692

object_name: benign meningioma


subject: CHEBI:50692

object_name: familial meningioma


subject: CHEBI:50692

object_name: pediatric meningioma


subject: CHEBI:50692

object_name: meningioma


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: renal cell adenocarcinoma


subject: UNII:6XC1PAD3KF

object_name: renal cell carcinoma


subject: UNII:6XC1PAD3KF

object_name: childhood kidney cell carcinoma


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: history of alcohol use


subject: CHEBI:73604

object_name: alcohol dependence


subject: CHEBI:73604

object_name: alcohol-related disorders


subject: UMLS:C4287754

subject_name: Ragifilimab

object_name: Squamous cell carcinoma of head and neck metastatic


subject: UMLS:C4287754

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab


subject: UNII:2Y3T5IF01Z


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: UMLS:C5555852

subject_name: Anti-ROR1/CD3 T-cell Engager NVG-111

object_name: mantle cell lymphoma


subject: UMLS:C5555852

object_name: non-small cell lung carcinoma


subject: UMLS:C5555852

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5555852

object_name: melanoma


subject: UMLS:C5555852

object_name: follicular lymphoma


subject: UMLS:C5555852

object_name: diffuse large B-cell lymphoma


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:28976

subject_name: carbonic acid

object_name: chronic kidney disease


subject: CHEBI:28976


subject: CHEBI:28976

object_name: cardiovascular disorder


subject: UMLS:C2722820

subject_name: Bicarbonate preparation


subject: UMLS:C2722820


subject: UMLS:C2722820


subject: MESH:D001639

subject_name: Bicarbonates


subject: MESH:D001639


subject: MESH:D001639


subject: CHEBI:17544

subject_name: Bicarbonate Ion


subject: CHEBI:17544


subject: CHEBI:17544


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: pneumocystosis


subject: PUBCHEM.COMPOUND:91976568

subject_name: Teduglutide

object_name: HIV infection


subject: UMLS:C1098514


subject: PR:000007559

object_name: Renal anaemia


subject: UMLS:C2917382

subject_name: Erythropoiesis-stimulating Agent [EPC]


subject: PUBCHEM.COMPOUND:72728820

subject_name: Moxidectin

object_name: Infection


subject: PUBCHEM.COMPOUND:72728820

object_name: infectious disease


subject: PUBCHEM.COMPOUND:72728820

object_name: Adverse Event Associated with Infection


subject: PUBCHEM.COMPOUND:53397745

subject_name: Milbemycin A4


subject: PUBCHEM.COMPOUND:53397745


subject: PUBCHEM.COMPOUND:53397745


subject: PUBCHEM.COMPOUND:57369871

subject_name: Milbemycin D


subject: PUBCHEM.COMPOUND:57369871


subject: PUBCHEM.COMPOUND:57369871


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: Chronic Hemolysis


subject: PR:000014046

subject_name: non-secretory ribonuclease

object_name: liver carcinoma


subject: CHEBI:73024

subject_name: O-acetylcarnitine


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: CHEBI:77635

subject_name: calcium phosphate

object_name: osteoporosis


subject: CHEBI:77635

object_name: Encounter due to family history of osteoporosis


subject: CHEBI:77635

object_name: Osteoporosis, CTCAE 5.0


subject: CHEBI:77635

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:77635

object_name: Osteopenia


subject: CHEBI:9679


subject: CHEBI:9679


subject: CHEBI:9679


subject: CHEBI:9679


subject: CHEBI:3311

subject_name: Calcium carbonate


subject: CHEBI:28793

subject_name: beta-D-glucan

object_name: Flu symptoms


subject: CHEBI:28793

object_name: Cold symptoms


subject: CHEBI:28793

object_name: influenza


subject: CHEBI:28793

object_name: Stress


subject: CHEBI:28793

object_name: common cold


subject: CHEBI:28793

object_name: Upper Respiratory Infections


subject: CHEBI:28793

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:439262

subject_name: Beta-Glucan


subject: PUBCHEM.COMPOUND:439262


subject: PUBCHEM.COMPOUND:439262


subject: PUBCHEM.COMPOUND:439262


subject: PUBCHEM.COMPOUND:439262


subject: PUBCHEM.COMPOUND:439262


subject: PUBCHEM.COMPOUND:439262


subject: CHEBI:8378

subject_name: Prednisolone

object_name: pleural tuberculosis


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Advanced Malignant Skin Neoplasm


subject: UNII:52CMI0WC3Y

object_name: Metastatic Malignant Skin Neoplasm


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UNII:KXG2PJ551I


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UNII:6QVL057INT

subject_name: Cemiplimab


subject: UNII:6QVL057INT


subject: UMLS:C4053601


subject: UMLS:C4053601


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab


subject: UNII:P0GVQ9A4S5


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:2Y3T5IF01Z

subject_name: Retifanlimab


subject: UNII:2Y3T5IF01Z


subject: UMLS:C4688466

subject_name: INCMGA 0012


subject: UMLS:C4688466


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: CHEBI:47808

subject_name: Sulforaphane

object_name: type 2 diabetes mellitus


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: Thin-cap fibroatheroma


subject: UNII:PP0SHH6V16

object_name: coronary atherosclerosis


subject: UMLS:C5419453

subject_name: Probiotic Supplement WeiLeShu

object_name: colorectal cancer


subject: UMLS:C5419453

object_name: colorectal carcinoma


subject: UMLS:C5419453

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5419453

object_name: infectious disease


subject: CHEBI:233436

subject_name: Tolebrutinib

object_name: secondary progressive multiple sclerosis


subject: CHEBI:233436

object_name: progressive relapsing multiple sclerosis


subject: DRUGBANK:DB18715


subject: DRUGBANK:DB18715


subject: CHEBI:61606

object_name: postmenopausal osteoporosis


subject: CHEBI:61606

object_name: osteoporosis


subject: PUBCHEM.COMPOUND:53477767

subject_name: Hesperidin


subject: PUBCHEM.COMPOUND:53477767


subject: CHEBI:6456

subject_name: Lidocaine

object_name: abscess


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: cholestasis


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: CHEBI:45863

subject_name: Paclitaxel


subject: RXCUI:1591943

subject_name: ledipasvir 90 MG / sofosbuvir 400 MG Oral Tablet

object_name: chronic hepatitis C virus infection


subject: CHEBI:74698

subject_name: Met-Arg

object_name: congenital rubella syndrome


subject: PR:000011407

subject_name: mineralocorticoid receptor


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: Open fracture of tibia


subject: GTOPDB:2943

subject_name: secretin

object_name: Lynch syndrome


subject: GTOPDB:2943

object_name: Hereditary Nonpolyposis Colorectal Cancer


subject: CHEBI:232390


subject: CHEBI:232390


subject: UMLS:C5564711

object_name: Heart failure with normal ejection fraction


subject: MESH:C557525

subject_name: SB939 compound

object_name: prostate carcinoma


subject: MESH:C557525

object_name: prostate cancer


subject: CHEBI:5613

subject_name: Haloperidol

object_name: nicotine dependence


subject: CHEBI:44915

subject_name: Propofol

object_name: Valvular Heart Disease, CTCAE


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: heart valve disorder


subject: CHEBI:9130


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Leukemia - chronic myeloid leukemia (CML)


subject: CHEBI:17026

subject_name: Progesterone

object_name: Hormone receptor positive tumor


subject: CHEBI:17026

object_name: Early Stage Breast Carcinoma


subject: CHEBI:41774

subject_name: Tamoxifen


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: kidney disorder


subject: CHEBI:63598

subject_name: Levofloxacin


subject: MESH:C528970

object_name: Carcinoma breast stage IV


subject: CHEBI:135901

subject_name: lanreotide

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C0051846

subject_name: angiopeptin


subject: CHEBI:44915

object_name: Burn injury


subject: CHEBI:44915

object_name: Surgical wound


subject: UMLS:C0591440

subject_name: Eltroxin

object_name: central congenital hypothyroidism


subject: UMLS:C2584344

subject_name: Sominex brand of promethazine

object_name: insomnia


subject: UMLS:C2584344

object_name: Insomnia, CTCAE 3.0


subject: UMLS:C2584344

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: CHEBI:4636


subject: CHEBI:4636


subject: UNII:HQ700V0X06

subject_name: INUPADENANT

object_name: Adult Solid Neoplasm


subject: DRUGBANK:DB19129

subject_name: Inupadenant


subject: GTOPDB:11607

subject_name: barzolvolimab

object_name: atopic eczema


subject: UNII:4B77GX0NA3

subject_name: BARZOLVOLIMAB


subject: UMLS:C5669595

subject_name: Barzolvolimab


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: Craving


subject: HMDB:HMDB0013470

object_name: Inflammatory Response


subject: HMDB:HMDB0013470

object_name: alcohol abuse


subject: HMDB:HMDB0013470

object_name: alcohol dependence


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:89981


subject: CHEBI:89981


subject: CHEBI:89981


subject: CHEBI:53248

subject_name: Povidone

object_name: dry eye syndrome


subject: CHEBI:53248

object_name: Dry Eye, CTCAE


subject: CHEBI:53248

object_name: Dryness of eye


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:173077


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: renal transplant infection


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:46662

subject_name: mineral

object_name: emotional dysfunction


subject: CHEBI:46662

object_name: Irritability


subject: CHEBI:33704

subject_name: Amino acid


subject: CHEBI:33704


subject: PUBCHEM.COMPOUND:169449957

subject_name: Amino Acids


subject: PUBCHEM.COMPOUND:169449957


subject: CHEMBL.COMPOUND:CHEMBL1201498

subject_name: AMINO ACIDS


subject: CHEMBL.COMPOUND:CHEMBL1201498


subject: UMLS:C3539946

subject_name: Amino Acids, I.V. solution additive


subject: UMLS:C3539946


subject: UMLS:C0002520


subject: UMLS:C0002520


subject: UMLS:C3539947

subject_name: Antifibrinolytic amino acids


subject: UMLS:C3539947


subject: UMLS:C1704298

subject_name: Recombinant Luteinizing Hormone

object_name: Encounter due to In vitro fertilization


subject: UMLS:C4684824

subject_name: Polyamine Analogue SBP-101

object_name: pancreatic neoplasm


subject: UMLS:C4684824

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4684824

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: Huntington disease


subject: PUBCHEM.COMPOUND:3062

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:3062

object_name: Alzheimer disease


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:4551


subject: CHEBI:4551


subject: MESH:C000634404

object_name: liver failure


subject: UNII:M43ZDU10DD

subject_name: ICLEPERTIN


subject: DRUGBANK:DB19058

subject_name: Iclepertin


subject: UNII:AHU547PI9H

subject_name: Ferric derisomaltose

object_name: Chronic iron deficiency anaemia


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Heart Disease Risk Factors


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: Stomach cancer


subject: CHEBI:17061

object_name: gastric cancer


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:32696


subject: CHEBI:32696


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: GTOPDB:13718

subject_name: xaluritamig

object_name: Nonmetastatic Castration-Sensitive Prostate Carcinoma


subject: UNII:ODG03B9M4U

subject_name: XALURITAMIG


subject: UMLS:C5238964

subject_name: Xaluritamig


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Axial Spondyloarthritis


subject: CHEBI:49092

subject_name: D-Tagatose

object_name: type 2 diabetes mellitus


subject: CHEBI:47693

subject_name: Tagatose


subject: CHEBI:33954

subject_name: tagatose


subject: CHEBI:17968

subject_name: butyrate

object_name: metabolic disease


subject: MESH:D002087

subject_name: Butyrates


subject: CHEBI:30772

subject_name: Butyric Acid


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:4026

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: CHEBI:4026

object_name: Stage II Adult Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Stage I Adult Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Untreated Hairy Cell Leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:91872

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:91872

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:91872

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:91872

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:91872

object_name: B-cell small lymphocytic lymphoma stage I


subject: CHEBI:91872

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:91872

object_name: Stage I Adult Immunoblastic Lymphoma


subject: CHEBI:91872

object_name: B-cell small lymphocytic lymphoma stage II


subject: CHEBI:91872

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:91872

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:91872


subject: CHEBI:91872

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:91872

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:91872

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:91872

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: CHEBI:91872

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:91872

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: CHEBI:91872

object_name: Marginal zone lymphoma stage III


subject: CHEBI:91872

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:91872

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:91872

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: CHEBI:91872

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:91872

object_name: Marginal zone lymphoma stage I


subject: CHEBI:91872

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:91872

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:91872

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:91872

object_name: Stage I Adult Hodgkin Lymphoma


subject: CHEBI:91872

object_name: Untreated Hairy Cell Leukemia


subject: CHEBI:91872

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: CHEBI:91872

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: CHEBI:91872

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:91872

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:91872

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:91872

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:91872

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: CHEBI:91872

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: CHEBI:91872

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:91872

object_name: Chronic lymphocytic leukaemia stage 2


subject: CHEBI:91872

object_name: Chronic lymphocytic leukaemia stage 0


subject: CHEBI:91872

object_name: Chronic lymphocytic leukaemia stage 1


subject: CHEBI:91872

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28748

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:28748

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28748

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:28748

object_name: B-cell small lymphocytic lymphoma stage I


subject: CHEBI:28748

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28748

object_name: Stage I Adult Immunoblastic Lymphoma


subject: CHEBI:28748

object_name: B-cell small lymphocytic lymphoma stage II


subject: CHEBI:28748

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:28748

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:28748

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:28748

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28748

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28748

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28748

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: CHEBI:28748

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28748

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: CHEBI:28748

object_name: Marginal zone lymphoma stage III


subject: CHEBI:28748

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28748

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28748

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: CHEBI:28748

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28748

object_name: Marginal zone lymphoma stage I


subject: CHEBI:28748

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:28748

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:28748

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:28748

object_name: Stage I Adult Hodgkin Lymphoma


subject: CHEBI:28748

object_name: Untreated Hairy Cell Leukemia


subject: CHEBI:28748

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: CHEBI:28748

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: CHEBI:28748

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:28748

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:28748

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:28748

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:28748

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: CHEBI:28748

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: CHEBI:28748

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:28748

object_name: Chronic lymphocytic leukaemia stage 2


subject: CHEBI:28748

object_name: Chronic lymphocytic leukaemia stage 0


subject: CHEBI:28748

object_name: Chronic lymphocytic leukaemia stage 1


subject: CHEBI:28748

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:4911

subject_name: Etoposide

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: CHEBI:4911

object_name: Stage I Adult Diffuse Large Cell Lymphoma


subject: CHEBI:4911

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: CHEBI:4911

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4911

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:4911

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4911

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:4911

object_name: B-cell small lymphocytic lymphoma stage I


subject: CHEBI:4911

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4911

object_name: Stage I Adult Immunoblastic Lymphoma


subject: CHEBI:4911

object_name: B-cell small lymphocytic lymphoma stage II


subject: CHEBI:4911

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:4911

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:4911

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:4911

object_name: Stage II Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:4911

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:4911

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:4911

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: CHEBI:4911

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: CHEBI:4911

object_name: Marginal zone lymphoma stage III


subject: CHEBI:4911

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:4911

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:4911

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: CHEBI:4911

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:4911

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:4911

object_name: Marginal zone lymphoma stage I


subject: CHEBI:4911

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:4911

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:4911

object_name: Stage II Adult Hodgkin Lymphoma


subject: CHEBI:4911

object_name: Stage I Adult Hodgkin Lymphoma


subject: CHEBI:4911

object_name: Untreated Hairy Cell Leukemia


subject: CHEBI:4911

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: CHEBI:4911

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: CHEBI:4911

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:4911

object_name: Chronic lymphocytic leukaemia stage 2


subject: CHEBI:4911

object_name: Chronic lymphocytic leukaemia stage 0


subject: CHEBI:4911

object_name: Chronic lymphocytic leukaemia stage 1


subject: CHEBI:4911

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: CHEBI:63791

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:63791

object_name: Stage II Adult Hodgkin Lymphoma


subject: CHEBI:63791

object_name: Stage I Adult Hodgkin Lymphoma


subject: CHEBI:63791

object_name: Untreated Hairy Cell Leukemia


subject: CHEBI:63791

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:8382

subject_name: Prednisone

object_name: Mantle cell lymphoma stage I


subject: CHEBI:8382

object_name: Mantle cell lymphoma stage III


subject: CHEBI:8382

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:8382

object_name: small intestine lymphoma


subject: CHEBI:8382

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: CHEBI:8382

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:8382

object_name: intraocular lymphoma


subject: CHEBI:8382

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:8382

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:8382

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:8382

object_name: B-cell small lymphocytic lymphoma stage I


subject: CHEBI:8382

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:8382

object_name: Stage I Adult Immunoblastic Lymphoma


subject: CHEBI:8382

object_name: B-cell small lymphocytic lymphoma stage II


subject: CHEBI:8382

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:8382

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:8382

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:8382

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:8382

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:8382

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: CHEBI:8382

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:8382

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: CHEBI:8382

object_name: Marginal zone lymphoma stage III


subject: CHEBI:8382

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:8382

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:8382

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: CHEBI:8382

object_name: primary cutaneous B-cell lymphoma


subject: CHEBI:8382

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:8382

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:8382

object_name: Marginal zone lymphoma stage I


subject: CHEBI:8382

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:8382

object_name: Stage II Adult Hodgkin Lymphoma


subject: CHEBI:8382

object_name: Stage I Adult Hodgkin Lymphoma


subject: CHEBI:8382

object_name: Untreated Hairy Cell Leukemia


subject: CHEBI:8382

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:8382

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: CHEBI:8382

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: CHEBI:8382

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:8382

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:8382

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: CHEBI:8382

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: CHEBI:8382

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:8382

object_name: Chronic lymphocytic leukaemia stage 2


subject: CHEBI:8382

object_name: Chronic lymphocytic leukaemia stage 0


subject: CHEBI:8382

object_name: Chronic lymphocytic leukaemia stage 1


subject: CHEBI:8382

object_name: Chronic lymphocytic leukaemia stage 4


subject: UNII:T5IRO3534A

subject_name: Oncovin

object_name: small intestine lymphoma


subject: UNII:T5IRO3534A

object_name: testicular lymphoma


subject: UNII:T5IRO3534A

object_name: intraocular lymphoma


subject: UNII:T5IRO3534A

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: UNII:T5IRO3534A

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: UNII:T5IRO3534A

object_name: Stage III Adult Immunoblastic Lymphoma


subject: UNII:T5IRO3534A

object_name: B-cell small lymphocytic lymphoma stage I


subject: UNII:T5IRO3534A

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: UNII:T5IRO3534A

object_name: Stage I Adult Immunoblastic Lymphoma


subject: UNII:T5IRO3534A

object_name: B-cell small lymphocytic lymphoma stage II


subject: UNII:T5IRO3534A

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: UNII:T5IRO3534A

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: UNII:T5IRO3534A

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:T5IRO3534A

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:T5IRO3534A

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:T5IRO3534A

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: UNII:T5IRO3534A

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: UNII:T5IRO3534A

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: UNII:T5IRO3534A

object_name: Marginal zone lymphoma stage III


subject: UNII:T5IRO3534A

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: UNII:T5IRO3534A

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:T5IRO3534A

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: UNII:T5IRO3534A

object_name: primary cutaneous B-cell lymphoma


subject: UNII:T5IRO3534A

object_name: Stage III Adult Hodgkin Lymphoma


subject: UNII:T5IRO3534A

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: UNII:T5IRO3534A

object_name: Marginal zone lymphoma stage I


subject: UNII:T5IRO3534A

object_name: Marginal zone lymphoma stage IV


subject: UNII:T5IRO3534A

object_name: Stage II Adult Hodgkin Lymphoma


subject: UNII:T5IRO3534A

object_name: Stage I Adult Hodgkin Lymphoma


subject: UNII:T5IRO3534A

object_name: Untreated Hairy Cell Leukemia


subject: UNII:T5IRO3534A

object_name: Stage IV Adult Hodgkin Lymphoma


subject: UNII:T5IRO3534A

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: UNII:T5IRO3534A

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: UNII:T5IRO3534A

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:T5IRO3534A

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: UNII:T5IRO3534A

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: UNII:T5IRO3534A

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: UNII:T5IRO3534A

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: UNII:T5IRO3534A

object_name: Chronic lymphocytic leukaemia stage 3


subject: UNII:T5IRO3534A

object_name: Chronic lymphocytic leukaemia stage 2


subject: UNII:T5IRO3534A

object_name: Chronic lymphocytic leukaemia stage 0


subject: UNII:T5IRO3534A

object_name: Chronic lymphocytic leukaemia stage 1


subject: UNII:T5IRO3534A

object_name: Chronic lymphocytic leukaemia stage 4


subject: UNII:T5IRO3534A

object_name: Waldenstrom macroglobulinemia


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine

object_name: small intestine lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: testicular lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: intraocular lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage III Adult Immunoblastic Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: B-cell small lymphocytic lymphoma stage I


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage I Adult Immunoblastic Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: B-cell small lymphocytic lymphoma stage II


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Marginal zone lymphoma stage III


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: PUBCHEM.COMPOUND:3717450

object_name: primary cutaneous B-cell lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage III Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Marginal zone lymphoma stage I


subject: PUBCHEM.COMPOUND:3717450

object_name: Marginal zone lymphoma stage IV


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage II Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage I Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Untreated Hairy Cell Leukemia


subject: PUBCHEM.COMPOUND:3717450

object_name: Stage IV Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:3717450

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: PUBCHEM.COMPOUND:3717450

object_name: Chronic lymphocytic leukaemia stage 3


subject: PUBCHEM.COMPOUND:3717450

object_name: Chronic lymphocytic leukaemia stage 2


subject: PUBCHEM.COMPOUND:3717450

object_name: Chronic lymphocytic leukaemia stage 0


subject: PUBCHEM.COMPOUND:3717450

object_name: Chronic lymphocytic leukaemia stage 1


subject: PUBCHEM.COMPOUND:3717450

object_name: Chronic lymphocytic leukaemia stage 4


subject: PUBCHEM.COMPOUND:3717450

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:28445

subject_name: vincristine

object_name: Stage III Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28445

object_name: Stage I Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28445

object_name: Stage III Adult Immunoblastic Lymphoma


subject: CHEBI:28445

object_name: B-cell small lymphocytic lymphoma stage I


subject: CHEBI:28445

object_name: Stage IV Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28445

object_name: Stage I Adult Immunoblastic Lymphoma


subject: CHEBI:28445

object_name: B-cell small lymphocytic lymphoma stage II


subject: CHEBI:28445

object_name: Stage IV Adult Immunoblastic Lymphoma


subject: CHEBI:28445

object_name: Adult Grade III Lymphomatoid Granulomatosis


subject: CHEBI:28445

object_name: Stage III Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28445

object_name: Stage I Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28445

object_name: Stage IV Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28445

object_name: Ann Arbor Stage II Adult Contiguous Immunoblastic Lymphoma


subject: CHEBI:28445

object_name: Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28445

object_name: Ann Arbor Stage II Adult Non-Contiguous Immunoblastic Lymphoma


subject: CHEBI:28445

object_name: Marginal zone lymphoma stage III


subject: CHEBI:28445

object_name: Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:28445

object_name: Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28445

object_name: Progressive Hairy Cell Leukemia Initial Treatment


subject: CHEBI:28445

object_name: Stage III Adult Hodgkin Lymphoma


subject: CHEBI:28445

object_name: Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:28445

object_name: Marginal zone lymphoma stage I


subject: CHEBI:28445

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:28445

object_name: Stage II Adult Hodgkin Lymphoma


subject: CHEBI:28445

object_name: Stage I Adult Hodgkin Lymphoma


subject: CHEBI:28445

object_name: Untreated Hairy Cell Leukemia


subject: CHEBI:28445

object_name: Stage IV Adult Hodgkin Lymphoma


subject: CHEBI:28445

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: CHEBI:28445

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: CHEBI:28445

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:28445

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:28445

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: CHEBI:28445

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: CHEBI:28445

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:28445

object_name: Chronic lymphocytic leukaemia stage 2


subject: CHEBI:28445

object_name: Chronic lymphocytic leukaemia stage 0


subject: CHEBI:28445

object_name: Chronic lymphocytic leukaemia stage 1


subject: CHEBI:28445

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:132082

subject_name: Entinostat

object_name: renal carcinoma


subject: CHEBI:132082

object_name: kidney cancer


subject: CHEBI:132082

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:132082

object_name: Embolism, Tumor


subject: CHEBI:132082

object_name: Neoplasm Metastasis


subject: CHEBI:230682

subject_name: Indoximod

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:230682

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:230682

object_name: metastatic melanoma


subject: CHEBI:230682

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: CHEBI:94688

subject_name: Acipimox

object_name: dilated cardiomyopathy


subject: CHEBI:17154

subject_name: Nicotinamide

object_name: cutaneous lupus erythematosus


subject: CHEBI:17154

object_name: Systemic lupus erythematosus rash


subject: CHEBI:139072

object_name: amnesia


subject: CHEBI:139072

object_name: Amnesia, CTCAE


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:6931

subject_name: Midazolam

object_name: Psychedelic Experiences


subject: PUBCHEM.COMPOUND:155011957

subject_name: TGF-beta

object_name: melanoma


subject: PUBCHEM.COMPOUND:155011957

object_name: renal cell carcinoma


subject: CHEBI:6909

subject_name: Metronidazole

object_name: Colorectal cancer stage III


subject: CHEBI:6909

object_name: Colorectal cancer stage II


subject: UNII:U34EAV21TG

object_name: Kala-Azar


subject: UNII:5AIJ4TGC6B

subject_name: Sitamaquine


subject: UMLS:C5854575

subject_name: Anti-EGFR Antibody-drug Conjugate CPO301

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5557417

subject_name: Enlonstobart


subject: CHEBI:135529

subject_name: Revaprazan

object_name: Non-Erosive Reflux Disease


subject: CHEBI:230430

subject_name: Ulinastatin

object_name: acute kidney failure


subject: CHEBI:230430

object_name: Acute Kidney Injury, CTCAE


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: UNII:OR3S9IF86U


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: CHEMBL.COMPOUND:CHEMBL2108163


subject: UMLS:C0077906


subject: UMLS:C0077906


subject: UNII:JFU9WH6LCH

subject_name: LACTOBACILLUS PLANTARUM ECGC 13110402

object_name: Hypercholesterolemia


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Castleman disease


subject: CHEBI:9168

object_name: multicentric Castleman disease


subject: UMLS:C1722701

subject_name: Licartin

object_name: Unresectable Hepatocellular Carcinoma


subject: UMLS:C4056500

subject_name: soluble corn fiber

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C4056500

object_name: obesity


subject: UMLS:C4056500

object_name: Obesity, CTCAE


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:9150

object_name: Carcinoma breast stage I


subject: CHEBI:9150

object_name: Breast cancer stage II


subject: CHEBI:9150

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:9150

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:9150

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:9150

object_name: Breast cancer stage III


subject: CHEBI:9150

object_name: Stage III Breast Cancer AJCC v6


subject: CHEBI:15365

subject_name: Aspirin

object_name: Pharyngalgia


subject: CHEBI:8024

subject_name: Perindopril

object_name: myocardial ischemia


subject: CHEBI:8024

object_name: Family history of ischemic heart disease


subject: RXCUI:1291861

subject_name: Dymista

object_name: Allergic Rhinitis, CTCAE


subject: CHEBI:27732

subject_name: Caffeine

object_name: INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1


subject: CHEBI:16243

subject_name: Quercetin

object_name: airway; obstruction, with bronchitis (chronic)


subject: CHEBI:16243

object_name: emphysema


subject: UNII:7K28NB895L

subject_name: Belzutifan

object_name: Childhood Solid Neoplasm


subject: UNII:7K28NB895L

object_name: Adult Solid Neoplasm


subject: UNII:7K28NB895L

object_name: Solid Neoplasm


subject: UNII:7K28NB895L

object_name: glioblastoma


subject: UNII:7K28NB895L

object_name: refractory cytopenia of childhood


subject: UNII:7K28NB895L

object_name: Solid carcinoma


subject: UNII:7K28NB895L

object_name: Brain Stem Glioblastoma


subject: UNII:7K28NB895L

object_name: glioma susceptibility 1


subject: UNII:7K28NB895L

object_name: adult glioblastoma


subject: UNII:7K28NB895L

object_name: Childhood Glioblastoma


subject: UMLS:C0699318

subject_name: Endoxana

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C0699318

object_name: clear cell renal carcinoma


subject: UMLS:C0699318

object_name: renal cell adenocarcinoma


subject: UMLS:C0699318

object_name: renal cell carcinoma


subject: UMLS:C2347949


subject: UMLS:C2347949


subject: UMLS:C2347949


subject: UMLS:C2347949


subject: CHEBI:132967

subject_name: Elbasvir

object_name: Chronic hepatitis C genotype 1b


subject: CHEBI:132967

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:132967

object_name: metabolic syndrome X


subject: CHEBI:132967

object_name: Liver Fibrosis


subject: UMLS:C5666924

subject_name: Anti-CD137 Agonistic Monoclonal Antibody YH004

object_name: cancer


subject: UMLS:C5666924

object_name: neoplasm


subject: CHEBI:60802

subject_name: ropivacaine

object_name: benign female reproductive system neoplasm


subject: CHEBI:8805

subject_name: Repaglinide

object_name: cystic fibrosis


subject: CHEBI:9434

subject_name: Telmisartan

object_name: Heart Failure, CTCAE


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: diabetes mellitus


subject: UMLS:C5139953

object_name: chronic kidney disease


subject: UMLS:C5139953

object_name: Chronic uremia


subject: UMLS:C5139821

subject_name: Efinopegdutide


subject: UMLS:C5139821


subject: CHEBI:228696

object_name: endogenous depression


subject: CHEBI:228696

object_name: major depressive disorder


subject: CHEBI:5558

subject_name: Guanfacine

object_name: obstructive sleep apnea syndrome


subject: CHEBI:5778

subject_name: Hydrochlorothiazide


subject: UMLS:C5561179

subject_name: ropeginterferon alfa-2b-njft

object_name: essential thrombocythemia


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage IV Bladder Cancer AJCC v7


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IV Bladder Cancer AJCC v6


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Stage III Bladder Cancer AJCC v6 and v7


subject: CHEBI:9168

object_name: Stage III Bladder Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage II Bladder Cancer AJCC v6 and v7


subject: CHEBI:9168

object_name: Stage II Bladder Cancer AJCC v8


subject: CHEBI:9168

object_name: Stage IV Bladder Cancer AJCC v8


subject: CHEBI:9168


subject: CHEBI:9168

object_name: Bladder cancer stage IV


subject: CHEBI:9168


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran

object_name: acute leukemia


subject: UNII:JSV288Q5CV

object_name: acute myeloid leukemia by FAB classification


subject: UNII:JSV288Q5CV

object_name: acute myeloid leukemia


subject: UNII:JSV288Q5CV

object_name: acute lymphoblastic leukemia


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Osteoarthritis of ankle


subject: CHEBI:8776

subject_name: ranitidine


subject: CHEBI:4636

subject_name: Diphenhydramine


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: PUBCHEM.COMPOUND:633097

object_name: vitiligo


subject: CHEBI:18248

subject_name: Iron

object_name: Encounter for being a bone marrow donor


subject: CHEBI:29034

subject_name: Ferric cation


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UMLS:C2827524

subject_name: Aurora Kinase Inhibitor TTP607

object_name: adult lymphoma


subject: UMLS:C2827524

object_name: lymphoma


subject: UMLS:C2827524

object_name: pediatric lymphoma


subject: GTOPDB:12989

subject_name: toripalimab

object_name: Adult Hodgkin Lymphoma


subject: GTOPDB:12989

object_name: Childhood Hodgkin Lymphoma


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UNII:OSL3FEZ1IF

subject_name: Lisaftoclax

object_name: Higher Risk Myelodysplastic Syndrome


subject: UMLS:C4744685


subject: CHEBI:16867

subject_name: D-Methionine

object_name: Leber hereditary optic neuropathy


subject: UMLS:C1744076

subject_name: CytoFab

object_name: Severe Sepsis


subject: GTOPDB:8002

subject_name: bavituximab

object_name: HIV infection


subject: UNII:Q16CT95N25


subject: UMLS:C1707382


subject: PUBCHEM.COMPOUND:11255911

subject_name: Tesofensine

object_name: Alzheimer disease type 1


subject: PUBCHEM.COMPOUND:11255911

object_name: Alzheimer disease


subject: UMLS:C0305062

subject_name: Tetanus Toxoid

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C0305062

object_name: acute myeloid leukemia


subject: UMLS:C0305062

object_name: Myelodysplasia


subject: UMLS:C0305062

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0305062

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0305062

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C0305062

object_name: acute lymphoblastic leukemia


subject: UMLS:C0305062

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C0305062

object_name: non-Hodgkin lymphoma


subject: UMLS:C0305062

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C0305062

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C0305062

object_name: Hodgkin Disease


subject: UMLS:C0305062

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C0305062

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Dyslipidemia due to type 2 diabetes mellitus


subject: CHEBI:74947

subject_name: Thalidomide

object_name: appendix carcinoma


subject: UMLS:C5908034

subject_name: Anti-B7-H4/Anti-4-1BB Bispecific Antibody ABL103

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:108169

subject_name: Taxane


subject: UMLS:C0796419

subject_name: Taxanes


subject: CHEBI:60791

subject_name: Xylocard

object_name: insomnia


subject: CHEBI:60791

object_name: Insomnia, CTCAE 3.0


subject: CHEBI:60791

object_name: Insomnia, CTCAE 5.0


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:6456


subject: UNII:UH8E2N30I7

object_name: Anetoderma


subject: UNII:UH8E2N30I7

object_name: macular degeneration


subject: UNII:UH8E2N30I7

object_name: age-related macular degeneration


subject: UNII:UH8E2N30I7

object_name: retinitis pigmentosa 30


subject: UNII:UH8E2N30I7

object_name: retinal degeneration


subject: UNII:UH8E2N30I7

object_name: retinal disease


subject: UNII:UH8E2N30I7

object_name: Geographic atrophy


subject: UNII:UH8E2N30I7

object_name: eye disorder


subject: GTOPDB:13769

subject_name: retatrutide

object_name: osteoarthritis, knee


subject: CHEMBL.COMPOUND:CHEMBL5095485

subject_name: RETATRUTIDE


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: Neurosis


subject: CHEBI:6367

object_name: Compulsion


subject: MESH:C479877

object_name: hypertension


subject: MESH:C479877

object_name: Hypertension, CTCAE


subject: UNII:9603LN7R2Q

subject_name: Creatine Monohydrate

object_name: juvenile dermatomyositis


subject: CHEBI:52970


subject: CHEBI:60899


subject: CHEBI:177490


subject: CHEBI:167578


subject: CHEBI:64183

subject_name: Ubiquinol


subject: UMLS:C4547429

object_name: Alzheimer disease


subject: UNII:80K4H2RB8P

subject_name: Indibulin

object_name: Carcinoma breast stage IV


subject: UMLS:C0771180

subject_name: dextrose 15 % in water

object_name: epicondylitis


subject: UMLS:C0770259

subject_name: Dextrose 5% and Water


subject: UNII:VR5Y7PDT5W

subject_name: ISOTONIC SODIUM CHLORIDE SOLUTION


subject: CHEBI:15940

subject_name: Niacin

object_name: Parkinson disease


subject: CHEBI:17154

subject_name: Nicotinamide


subject: CHEBI:25017

subject_name: leucine

object_name: cerebral palsy


subject: CHEBI:25017

object_name: mixed cerebral palsy


subject: CHEBI:25017

object_name: ataxic cerebral palsy


subject: CHEBI:25017

object_name: cerebral palsy, ataxic, autosomal recessive


subject: UMLS:C0752700

object_name: lung cancer


subject: UMLS:C0752700

object_name: lung neoplasm


subject: UMLS:C0752700

object_name: lung carcinoma


subject: UMLS:C0752700

object_name: Drug toxicity


subject: UMLS:C0752700

object_name: leukopenia


subject: UMLS:C0752700

object_name: neutropenia


subject: UMLS:C0752700

object_name: anemia


subject: UMLS:C0752700

object_name: Anemia, CTCAE


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: CHEBI:31198

subject_name: Ambroxol hydrochloride

object_name: Cough


subject: CHEBI:31198

object_name: Cough, CTCAE


subject: UNII:CC995ZMV90

subject_name: AMBROXOL HYDROCHLORIDE


subject: UNII:CC995ZMV90


subject: CHEBI:135590

subject_name: Ambroxol


subject: CHEBI:135590


subject: PUBCHEM.COMPOUND:76853547

subject_name: Simotinib hydrochloride

object_name: non-small cell lung carcinoma


subject: UMLS:C4733368

subject_name: simotinib hydrochloride


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: failure; transplant, kidney


subject: PUBCHEM.COMPOUND:70789204

object_name: Graft failure


subject: CHEBI:9316

subject_name: Sufentanil

object_name: traumatic encephalopathy


subject: CHEBI:9316

object_name: traumatic brain injury


subject: UNII:HV6MT68KKF

subject_name: SEVIRUMAB

object_name: cytomegalovirus infection


subject: UMLS:C0914798

subject_name: sevirumab


subject: CHEBI:8389

subject_name: conjugated estrogens

object_name: pelvic organ prolapse


subject: CHEBI:17474

subject_name: Estrone sulfate


subject: CHEBI:17474

object_name: Menopause present (finding)


subject: CHEBI:17474

object_name: Menopause


subject: PUBCHEM.COMPOUND:45357473

subject_name: Estratab


subject: CHEBI:39465

subject_name: timolol

object_name: capillary infantile hemangioma


subject: CHEBI:39465

object_name: Spider nevus


subject: UMLS:C2983764

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:231693

subject_name: Capmatinib


subject: CHEBI:174615

object_name: childhood malignant neoplasm


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:681569

subject_name: Clofarabine


subject: UNII:PE952ANF83

subject_name: Uproleselan


subject: UNII:J241Y80EEO

subject_name: Emraclidine

object_name: kidney failure


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Antineoplastic chemotherapy induced anemia


subject: GTOPDB:11552

subject_name: ziltivekimab

object_name: coronary artery disorder


subject: GTOPDB:11552

object_name: coronary atherosclerosis


subject: GTOPDB:11552

object_name: Coronary atherosclerosis of native coronary artery


subject: CHEMBL.COMPOUND:CHEMBL4297732

subject_name: ZILTIVEKIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297732


subject: CHEMBL.COMPOUND:CHEMBL4297732


subject: UMLS:C5419333


subject: UMLS:C5419333


subject: UMLS:C5419333


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: interstitial cystitis


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:145588


subject: PUBCHEM.COMPOUND:168359761

subject_name: Chondroitin sulfate


subject: CHEBI:145591


subject: CHEMBL.COMPOUND:CHEMBL4297689


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: obesity


subject: CHEMBL.COMPOUND:CHEMBL4297689

object_name: Obesity, CTCAE


subject: UMLS:C2346454


subject: UMLS:C2346454


subject: UMLS:C2346454


subject: UMLS:C2346454


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: pancreatic neoplasm


subject: UNII:15C2VL427D

object_name: malignant pancreatic neoplasm


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: cervical cancer


subject: CHEBI:73604

object_name: cervical carcinoma


subject: UMLS:C5854399

object_name: opiate dependence


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Fracture, CTCAE


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:50217

subject_name: selegiline

object_name: schizophrenia


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:4636

object_name: myoclonic dystonia 11


subject: CHEMBL.COMPOUND:CHEMBL4298131

subject_name: VIBECOTAMAB

object_name: acute myeloid leukemia


subject: CHEMBL.COMPOUND:CHEMBL4298131

object_name: Myelodysplasia


subject: CHEMBL.COMPOUND:CHEMBL4298131


subject: CHEMBL.COMPOUND:CHEMBL4298131


subject: UMLS:C4722674

subject_name: Vibecotamab


subject: UMLS:C4722674


subject: UMLS:C4722674


subject: CHEMBL.COMPOUND:CHEMBL1187846

subject_name: SCOPOLAMINE

object_name: Vomiting, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL1187846

object_name: Vomiting


subject: CHEMBL.COMPOUND:CHEMBL1187846

object_name: Nausea, CTCAE_5


subject: CHEMBL.COMPOUND:CHEMBL1187846

object_name: Nausea


subject: CHEMBL.COMPOUND:CHEMBL1187846

object_name: Nausea, CTCAE_3


subject: KEGG.COMPOUND:C01851

subject_name: Scopolamine


subject: KEGG.COMPOUND:C01851


subject: KEGG.COMPOUND:C01851


subject: KEGG.COMPOUND:C01851


subject: KEGG.COMPOUND:C01851


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: CHEBI:91541


subject: UMLS:C3537192

subject_name: Tumor Necrosis Factor Inhibitors

object_name: spondyloarthropathy


subject: UMLS:C3537192

object_name: enthesitis


subject: CHEBI:191250

subject_name: Lifibrol

object_name: Hypercholesterolemia


subject: CHEBI:191250

object_name: hyperlipoproteinemia


subject: UNII:09QCEV5481

subject_name: Tildacerfont

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:44195571

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:44195571

object_name: lymphoma


subject: PUBCHEM.COMPOUND:44195571

object_name: pediatric lymphoma


subject: UNII:BF52J69Q8T


subject: UNII:BF52J69Q8T


subject: UNII:BF52J69Q8T


subject: PUBCHEM.COMPOUND:156538665

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: PUBCHEM.COMPOUND:156538665

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:156538665


subject: PUBCHEM.COMPOUND:156538665

object_name: Activating EGFR Gene Mutation


subject: PUBCHEM.COMPOUND:156538665

object_name: EGFR-TKI Resistant Mutation


subject: PUBCHEM.COMPOUND:156538665

object_name: EGFR gene mutation


subject: PUBCHEM.COMPOUND:156538665

object_name: EGFR exon 19 deletion


subject: PUBCHEM.COMPOUND:156538665

object_name: Neoplasms by Histologic Type


subject: PUBCHEM.COMPOUND:156538665

object_name: respiratory tract neoplasm


subject: PUBCHEM.COMPOUND:156538665

object_name: respiratory system disorder


subject: PUBCHEM.COMPOUND:156538665

object_name: nervous system cancer


subject: PUBCHEM.COMPOUND:156538665

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:156538665

object_name: lung disorder


subject: PUBCHEM.COMPOUND:156538665

object_name: bronchogenic carcinoma


subject: PUBCHEM.COMPOUND:156538665

object_name: cancer


subject: PUBCHEM.COMPOUND:156538665

object_name: bronchial neoplasm


subject: PUBCHEM.COMPOUND:156538665

object_name: neoplasm of thorax


subject: PUBCHEM.COMPOUND:156538665

object_name: esophageal adenocarcinoma


subject: PUBCHEM.COMPOUND:156538665

object_name: lung adenocarcinoma


subject: PUBCHEM.COMPOUND:156538665

object_name: cervical adenocarcinoma


subject: PUBCHEM.COMPOUND:156538665

object_name: adenocarcinoma


subject: PUBCHEM.COMPOUND:156538665

object_name: bile duct adenocarcinoma


subject: PUBCHEM.COMPOUND:156538665

object_name: gastric adenocarcinoma


subject: PUBCHEM.COMPOUND:156538665

object_name: carcinoma


subject: PUBCHEM.COMPOUND:156538665

object_name: neoplasm


subject: UMLS:C5556543

subject_name: EGFR MUTANT-SELECTIVE INHIBITOR BLU-945

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: UMLS:C5556543

object_name: non-small cell lung carcinoma


subject: UMLS:C5556543


subject: UMLS:C5556543

object_name: Activating EGFR Gene Mutation


subject: UMLS:C5556543

object_name: EGFR-TKI Resistant Mutation


subject: UMLS:C5556543

object_name: EGFR gene mutation


subject: UMLS:C5556543

object_name: EGFR exon 19 deletion


subject: UMLS:C5556543

object_name: Neoplasms by Histologic Type


subject: UMLS:C5556543

object_name: respiratory tract neoplasm


subject: UMLS:C5556543

object_name: respiratory system disorder


subject: UMLS:C5556543

object_name: nervous system cancer


subject: UMLS:C5556543

object_name: lung neoplasm


subject: UMLS:C5556543

object_name: lung disorder


subject: UMLS:C5556543

object_name: bronchogenic carcinoma


subject: UMLS:C5556543

object_name: cancer


subject: UMLS:C5556543

object_name: bronchial neoplasm


subject: UMLS:C5556543

object_name: neoplasm of thorax


subject: UMLS:C5556543

object_name: esophageal adenocarcinoma


subject: UMLS:C5556543

object_name: lung adenocarcinoma


subject: UMLS:C5556543

object_name: cervical adenocarcinoma


subject: UMLS:C5556543

object_name: adenocarcinoma


subject: UMLS:C5556543

object_name: bile duct adenocarcinoma


subject: UMLS:C5556543

object_name: gastric adenocarcinoma


subject: UMLS:C5556543

object_name: carcinoma


subject: UMLS:C5556543

object_name: neoplasm


subject: UMLS:C5543883

object_name: Atopic rhinitis


subject: UMLS:C5543883

object_name: Hay fever


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: colon carcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: colon cancer


subject: CHEBI:40574

subject_name: acetyl group

object_name: HER2 positive breast carcinoma


subject: CHEBI:33337

subject_name: Actinium


subject: CHEBI:157787

subject_name: Ala-Cys


subject: PR:000004336

subject_name: acid ceramidase


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Intrauterine growth restriction (IUGR)


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:32599

object_name: Head Injury


subject: CHEBI:32599

object_name: concussion


subject: CHEBI:93776

subject_name: Pevonedistat

object_name: Plasma cell myeloma refractory


subject: CHEBI:93776

object_name: Plasma cell myeloma recurrent


subject: UMLS:C5827055

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C5827055

object_name: chronic progressive multiple sclerosis


subject: UMLS:C1289919

subject_name: Intravenous fluid

object_name: septic shock


subject: UMLS:C5666958

subject_name: FAP/CD40-targeting DARPin MP0317

object_name: Advanced Biliary Tract Carcinoma


subject: UMLS:C5666958

object_name: Advanced Bile Duct Carcinoma


subject: CHEBI:42797

subject_name: Gabapentin

object_name: bipolar disorder


subject: CHEBI:42797

object_name: Cannabis use


subject: CHEBI:42797

object_name: Cannabis use disorder, mild


subject: CHEBI:42797

object_name: Cannabis use disorder, severe


subject: CHEBI:42797

object_name: Cannabis use disorder, moderate


subject: CHEBI:42797

object_name: Schizoaffective disorder, bipolar type


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UMLS:C1721684

subject_name: lexatumumab


subject: CHEBI:55352

subject_name: (R)-Atenolol

object_name: Left ventricular hypertrophy


subject: CHEBI:2904

subject_name: Atenolol


subject: UMLS:C2703095

object_name: acute myeloid leukemia


subject: CHEBI:17606

subject_name: Iodine

object_name: glioblastoma


subject: CHEBI:17606

object_name: Brain Stem Glioblastoma


subject: CHEBI:17606

object_name: glioma susceptibility 1


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: New daily persistent headache


subject: DRUGBANK:DB17491

object_name: Solid Neoplasm


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: digestive system cancer


subject: UNII:8L7891MRB6

subject_name: Encorafenib


subject: MESH:C583002

object_name: diabetic macular edema


subject: UMLS:C5706540

subject_name: Anti-CTLA-4 Monoclonal Antibody SHR-8068

object_name: colorectal cancer


subject: UMLS:C5706540

object_name: colorectal carcinoma


subject: UMLS:C5706540

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Postthrombotic Syndrome


subject: CHEBI:3441

subject_name: Carvedilol

object_name: Chronic liver disease


subject: CHEBI:3441

object_name: Diastolic dysfunction


subject: UNII:C8ADC441ME

subject_name: Ivabradine


subject: UNII:C8ADC441ME


subject: UMLS:C2987400


subject: UMLS:C2987400

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C2987400

object_name: follicular lymphoma


subject: UMLS:C4547969

subject_name: apatinib mesylate

object_name: ovarian cancer


subject: UMLS:C4547969

object_name: ovarian neoplasm


subject: UNII:T7K20Y2GWY

subject_name: Corifollitropin alfa

object_name: hypogonadism


subject: CHEBI:16335

subject_name: Adenosine

object_name: Myocardial Reperfusion Injury


subject: CHEBI:16335

object_name: congenital heart disease


subject: UMLS:C1567379

object_name: Leukemia - chronic myeloid leukemia (CML)


subject: CHEBI:52172

subject_name: Nilotinib


subject: CHEBI:75998

subject_name: Trametinib

object_name: Malignant melanoma stage IV


subject: CHEBI:84094

subject_name: testosterone sulfate

object_name: toxic or drug-related embryofetopathy


subject: UMLS:C4721537

subject_name: Therapeutic Testosterone


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:60802

subject_name: ropivacaine

object_name: neurodegenerative disease


subject: CHEBI:60802

object_name: Degenerative lumbar spinal stenosis


subject: CHEBI:60802

object_name: Degenerative spondylolisthesis


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:3757

subject_name: Clonidine


subject: UMLS:C5206716

object_name: pleural mesothelioma


subject: UMLS:C5206716

object_name: malignant pleural mesothelioma


subject: UMLS:C5206716

object_name: non-small cell lung carcinoma


subject: CHEBI:6931

subject_name: Midazolam

object_name: hepatitis C


subject: CHEBI:8871

subject_name: Risperidone

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:8871

object_name: metabolic syndrome X


subject: UMLS:C5761796

subject_name: GVAX

object_name: colorectal cancer


subject: UMLS:C5761796

object_name: colorectal carcinoma


subject: UMLS:C5761796

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Dry Eye, CTCAE


subject: CHEBI:61057

object_name: Dryness of eye


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: UNII:Z3S2Z6H7B0

subject_name: BNC 105

object_name: metastatic colorectal cancer


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Blasts Under 20 Percent of Peripheral Blood White Cells


subject: UNII:M89N0Q7EQR

object_name: High Risk Myelodysplastic Syndrome


subject: UNII:M89N0Q7EQR

object_name: Blasts Under 20 Percent of Bone Marrow Nucleated Cells


subject: UNII:M89N0Q7EQR

object_name: Acute myeloid leukemia in remission


subject: UNII:M89N0Q7EQR


subject: UNII:M89N0Q7EQR

object_name: Adult Myelodysplastic Syndrome


subject: UNII:M89N0Q7EQR

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:M89N0Q7EQR

object_name: acute megakaryoblastic leukemia


subject: UNII:M89N0Q7EQR

object_name: erythroleukemia


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Acute Erythroid Leukemia


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: PR:000016295

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: PR:000016295

object_name: vitiligo


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: Metastatic malignant neoplasm to liver


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: functional gastric disease


subject: UMLS:C0699619

subject_name: Nutropin

object_name: Congenital IGHD


subject: UMLS:C0699619

object_name: Reduced circulating growth hormone concentration


subject: UNII:78FE5XHE27

object_name: osteoarthritis


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: maxillary sinusitis


subject: CHEBI:78825

subject_name: Avutometinib

object_name: Childhood Glioblastoma


subject: CHEBI:78825

object_name: adult glioblastoma


subject: CHEBI:78825

object_name: Recurrent Childhood Glioblastoma


subject: CHEBI:78825

object_name: Recurrent Glioblastoma


subject: UNII:53O87HA2QU

subject_name: Defactinib


subject: UNII:53O87HA2QU


subject: UNII:53O87HA2QU


subject: UNII:53O87HA2QU


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Locally Advanced Malignant Neoplasm


subject: UMLS:C4053601


subject: UNII:OX5LRQ5H6K

subject_name: FIANLIMAB


subject: UMLS:C4329332

subject_name: Fianlimab


subject: CHEBI:59111

subject_name: URUSHIOL I

object_name: non-small cell lung carcinoma


subject: CHEBI:59111


subject: UMLS:C0309720

subject_name: PDC, veterinary product


subject: UMLS:C0309720


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:21634109

object_name: osteonecrosis


subject: PUBCHEM.COMPOUND:21634109

object_name: avascular necrosis


subject: PUBCHEM.COMPOUND:21634109

object_name: Ischemic Necrosis


subject: PUBCHEM.COMPOUND:21634109

object_name: Avascular Necrosis, CTCAE


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: neoplasm


subject: UMLS:C4049150

object_name: neoplastic syndrome


subject: UMLS:C4049150


subject: UMLS:C4049150

object_name: neoplastic disease or syndrome


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: acute bronchiolitis


subject: UMLS:C3179331

object_name: Childhood Breast Carcinoma


subject: UMLS:C3179331

object_name: breast carcinoma


subject: UMLS:C3179331

object_name: breast cancer


subject: UMLS:C3817323

subject_name: Xartemis XR

object_name: Acute Pain


subject: GTOPDB:11761

subject_name: anumigilimab

object_name: sickle cell disease


subject: UNII:IA9ALH5N8D

subject_name: ANUMIGILIMAB


subject: UMLS:C5669594

subject_name: Anumigilimab


subject: UMLS:C5400018

subject_name: Defibrotide, Pig


subject: UMLS:C5400018

object_name: High Risk Neuroblastoma


subject: UMLS:C5400018

object_name: Childhood Neuroblastoma


subject: UMLS:C5400018

object_name: neuroblastoma


subject: UNII:438HCF2X0M

subject_name: Defibrotide


subject: UNII:438HCF2X0M


subject: UNII:438HCF2X0M


subject: UNII:438HCF2X0M


subject: PUBCHEM.COMPOUND:86278334

subject_name: Dalazatide

object_name: Chronic small plaque psoriasis


subject: UNII:6U0259J807

subject_name: DALAZATIDE


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: Allergy


subject: UMLS:C1145201

object_name: hypersensitivity reaction disease


subject: UMLS:C1145201

object_name: Emotional hypersensitivity


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: CHEBI:7931


subject: UNII:MZ37792Y8J

subject_name: Oprozomib

object_name: Solid Neoplasm


subject: UMLS:C2984209


subject: GTOPDB:6934

subject_name: crenezumab

object_name: Alzheimer disease type 1


subject: CHEMBL.COMPOUND:CHEMBL1743004

subject_name: CRENEZUMAB


subject: UMLS:C3493199


subject: CHEBI:88249

subject_name: Mirdametinib

object_name: dedifferentiated liposarcoma


subject: CHEBI:88249

object_name: Unresectable Liposarcoma


subject: CHEBI:88249

object_name: adult liposarcoma


subject: CHEBI:88249

object_name: liposarcoma


subject: CHEBI:88249

object_name: pediatric liposarcoma


subject: CHEBI:88249


subject: CHEBI:88249

object_name: Atypical Lipoma


subject: CHEBI:88249

object_name: well-differentiated liposarcoma


subject: CHEBI:88249

object_name: myxoid liposarcoma


subject: CHEBI:88249

object_name: myxoid/round cell liposarcoma


subject: CHEBI:88249

object_name: round cell liposarcoma


subject: CHEBI:88249

object_name: pleomorphic liposarcoma


subject: CHEBI:88249

object_name: Myxoid pleomorphic liposarcoma


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993


subject: CHEBI:85993